Given that Aβ deposition and tau hyperphosphorylation are key pathological hallmarks of AD, we examined whether BYHWD ameliorates these pathologies via modulation of the C/EBPβ/AEP signaling pathway. This evidence concerns the gene CEBPB and Alzheimer disease.